🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of acetaminophen, asserting the firms concealed alleged dangers that the medication presented to children's brain development.

The court filing follows thirty days after Former President Trump publicized an unverified association between taking Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against Johnson & Johnson, which once produced the drug, the exclusive pain medication approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "deceived the public by profiting off of discomfort and pushing pills regardless of the risks."

The company states there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These corporations deceived for years, knowingly endangering millions to boost earnings," Paxton, from the Republican party, declared.

The manufacturer stated officially that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its website, Kenvue also said it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a verified association between consuming paracetamol and autism."

Groups acting on behalf of doctors and healthcare providers concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in Tylenol - is a restricted selection for expectant mothers to treat pain and fever, which can present serious health risks if left untreated.

"In over twenty years of research on the consumption of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the use of acetaminophen in any trimester of pregnancy causes brain development issues in children," the association commented.

The court filing mentions recent announcements from the previous government in arguing the drug is potentially dangerous.

In recent weeks, the former president caused concern from medical authorities when he instructed pregnant women to "resist strongly" not to consume Tylenol when unwell.

The FDA then published an announcement that physicians should contemplate reducing the use of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in minors has not been established.

The Health Department head Kennedy, who manages the FDA, had pledged in spring to undertake "comprehensive study program" that would establish the origin of autism spectrum disorder in a short period.

But specialists cautioned that identifying a single cause of autism spectrum disorder - considered by experts to be the result of a complex mix of inherited and environmental factors - would prove challenging.

Autism is a category of enduring cognitive variation and impairment that impacts how persons encounter and interact with the environment, and is diagnosed using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is campaigning for the Senate - claims Kenvue and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

This legal action seeks to make the firms "eliminate any marketing or advertising" that asserts Tylenol is safe for pregnant women.

This legal action echoes the concerns of a collection of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in recently.

A federal judge dismissed the case, stating research from the family's specialists was not conclusive.